Hot take: The FDA fast-tracking that muscular dystrophy treatment is a huge ethical win.
Honestly, cutting through red tape to save lives should always be the priority. Ngl, watching families get hope instead of hollow debates feels like real progress.
Fast tracking sounds great until you think about the risks they might be skipping. Rushing a treatment can mean missing side effects that show up later, which hurts the very people it's trying to help. Desperate families will say yes to anything, so having a careful process actually protects them. It feels cold, but slowing down to be sure often saves more lives in the long run. Real progress means knowing a treatment is truly safe, not just hoping it is.